Multiple randomized-controlled trials have confirmed the efficacy of ketogenic diet therapy (KDT) for medication-resistant epilepsy. Emerging clinical evidence is revealing efficacy in KDTs for other neurologic, endocrine and psychiatric disorders.
A recent surge in interest using KDTs to treat medication-resistant bipolar and schizophrenia disorders is similar to the use of KDT in treating medication-resistant seizures in epilepsy. While clinical evidence is evolving from case reports to controlled studies, basic scientists are studying animal models to uncover mechanisms of action and to help identify ideal candidates.
Insulin resistance is a common symptom amongst patients in early research who are diagnosed with severe mental health disorders. Currently there are 15 clinical trials in progress listed in the NIH database to examine the efficacy of KDTs for mental health disorders.
KDTs can be effective when applied with medical supervision through a multidisciplinary approach. RDNs play a pivotal role in these developing applications and access to this emerging information is essential for successful implementation and management.
Alleviate your "fear of keto" by attending this session from a psychiatrist who has adopted KDT into his medical team and an RDN with over 30 years of experience in managing KDTs in multiple applications.